Patent classifications
A01N37/28
ANTIMICROBIAL COMPOSITION INCLUDING A DIHYDROXAMIC ACID AND METHODS OF INHIBITING MICROBIAL GROWTH UTILIZING THE SAME
Antimicrobial compositions and methods for inhibiting microbial growth are disclosed. The antimicrobial compositions can include an antimicrobial agent that includes a dihydroxamic acid having a carbon chain length less than or equal to 7.
ANTIMICROBIAL COMPOSITION INCLUDING A DIHYDROXAMIC ACID AND METHODS OF INHIBITING MICROBIAL GROWTH UTILIZING THE SAME
Antimicrobial compositions and methods for inhibiting microbial growth are disclosed. The antimicrobial compositions can include an antimicrobial agent that includes a dihydroxamic acid having a carbon chain length less than or equal to 7.
QUATERNARY AMINE FORMULATIONS AND USES THEREOF
The present disclosure relates to preservative compositions for and methods of preserving household formulations, such as detergents, or preserving topical cosmetic or toiletry formulations against microbiological contamination or growth. Specifically, the disclosure relates to preservative compositions comprising an effective amount of a quaternary amine compound, an effective amount of an antifungal, and a solvent. Further, the disclosure relates to cosmetic or toiletry formulations comprising such preservative compositions. The disclosure further relates to method of making and using such preservative compositions and such cosmetic or toiletry formulations comprising the same.
QUATERNARY AMINE FORMULATIONS AND USES THEREOF
The present disclosure relates to preservative compositions for and methods of preserving household formulations, such as detergents, or preserving topical cosmetic or toiletry formulations against microbiological contamination or growth. Specifically, the disclosure relates to preservative compositions comprising an effective amount of a quaternary amine compound, an effective amount of an antifungal, and a solvent. Further, the disclosure relates to cosmetic or toiletry formulations comprising such preservative compositions. The disclosure further relates to method of making and using such preservative compositions and such cosmetic or toiletry formulations comprising the same.
ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
The present invention provides a compound having the structure:
##STR00001##
ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
The present invention provides a compound having the structure:
##STR00001##
MIXTURES OF SABADILLA ALKALOIDS AND INSECT GROWTH REGULATORS AND USES THEREOF
The present invention is directed to pesticidal mixtures comprising sabadilla alkaloids and at least one insect growth regulator and methods of controlling pests including insects and mites by application of pesticidal mixtures comprising sabadilla alkaloids and at least one insect growth regulator.
MIXTURES OF SABADILLA ALKALOIDS AND INSECT GROWTH REGULATORS AND USES THEREOF
The present invention is directed to pesticidal mixtures comprising sabadilla alkaloids and at least one insect growth regulator and methods of controlling pests including insects and mites by application of pesticidal mixtures comprising sabadilla alkaloids and at least one insect growth regulator.
Boron-containing diacylhydrazine compounds
The present disclosure provides boron-containing diacylhydrazines having Formula I: ##STR00001##
and the pharmaceutically acceptable salts and solvates thereof, wherein A, R.sup.4, and R.sup.5 are defined as set forth in the specification. The present disclosure also provides the use of boron-containing diacylhydrazines is ecdysone receptor-based inducible gene expression systems. Thus, the present disclosure is useful for applications such as gene therapy, treatment of disease, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable.
Boron-containing diacylhydrazine compounds
The present disclosure provides boron-containing diacylhydrazines having Formula I: ##STR00001##
and the pharmaceutically acceptable salts and solvates thereof, wherein A, R.sup.4, and R.sup.5 are defined as set forth in the specification. The present disclosure also provides the use of boron-containing diacylhydrazines is ecdysone receptor-based inducible gene expression systems. Thus, the present disclosure is useful for applications such as gene therapy, treatment of disease, large scale production of proteins and antibodies, cell-based screening assays, functional genomics, proteomics, metabolomics, and regulation of traits in transgenic organisms, where control of gene expression levels is desirable.